TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Non-inferiority of Short-term Catheterization Following Fistula Repair Surgery
Brief Summary: This facility-based, multi-center randomized controlled trial (RCT) will test the non-inferiority of short-term (7 day) urethral catheterization compared to longer-term (14 day) urethral catheterization in terms of predicting fistula repair breakdown three months following urinary fistula repair surgery. The study will be conducted among 507 women with simple fistula presenting at 8 study sites in Sub-Saharan Africa for fistula repair surgery.


Options:
A: Arm Label: Study group 1; Type: EXPERIMENTAL; Interventions: Other: Removal of urethral catheter | Arm Label: Study group 2; Type: OTHER; Interventions: Other: Removal of urethral catheter | Intervention Type: OTHER; Name: Removal of urethral catheter; Assigned to Arm(s): Study group 1, Study group 2
B: Arm Label: 7-day catheterization; Type: EXPERIMENTAL; Interventions: Procedure: 7-day catheterization following fistula repair surgery | Arm Label: 14-day catheterization; Type: ACTIVE_COMPARATOR; Interventions: Procedure: 14 day catheterization | Intervention Type: PROCEDURE; Name: 7-day catheterization following fistula repair surgery; Assigned to Arm(s): 7-day catheterization | Intervention Type: PROCEDURE; Name: 14 day catheterization; Assigned to Arm(s): 14-day catheterization
C: Arm Label: Tamsulosin 0.4mg; Type: EXPERIMENTAL; Interventions: Drug: tamsulosin 0.4mg | Arm Label: Control; Type: PLACEBO_COMPARATOR; Interventions: Other: No medication | Intervention Type: DRUG; Name: tamsulosin 0.4mg; Assigned to Arm(s): Tamsulosin 0.4mg | Intervention Type: OTHER; Name: No medication; Assigned to Arm(s): Control
D: Arm Label: Foley; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: No Foley; Type: ACTIVE_COMPARATOR; Interventions: Other: No Foley | Intervention Type: OTHER; Name: No Foley; Assigned to Arm(s): No Foley

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized Controlled Trial of Mailed Nicotine Replacement Therapy to Canadian Smokers
Brief Summary: This study will examine the efficacy of mailed distribution of free Nicotine Replacement Therapy to smokers. Telephone numbers will be randomly selected from across Canada in order to recruit adult smokers interested in completing a smoking survey and willing to be interviewed again in 8 weeks and 6 months time. Study participants will be asked about their smoking history and a hypothetical question: would they be interested in receiving the nicotine patch if this were to be provided to them free of charge? Participants expressing interest will be randomly assigned to one of two groups. One group will be offered the opportunity to actually receive a program of 5 weeks of the nicotine patch for free right away and the other group will not be offered the free nicotine patches. The proportions of smokers in the two groups who quit smoking by the 6-month interview will be compared.


Options:
A: Intervention Type: DRUG; Name: rimonabant (SR141716); Assigned to Arm(s): N/A
B: Arm Label: Nicotine Replacement Therapy; Type: EXPERIMENTAL; Interventions: Drug: Nicotine replacement therapy | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Nicotine replacement therapy; Assigned to Arm(s): Nicotine Replacement Therapy
C: Arm Label: PROOF cohort; Type: N/A; Interventions: Other: Sleep apnea/hypopnea detection | Intervention Type: OTHER; Name: Sleep apnea/hypopnea detection; Assigned to Arm(s): PROOF cohort
D: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: nicotine patch | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Drug: nicotine lozenge | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Drug: nicotine patch + nicotine lozenge | Arm Label: 4; Type: EXPERIMENTAL; Interventions: Drug: bupropion | Arm Label: 5; Type: EXPERIMENTAL; Interventions: Drug: bupropion + lozenge | Arm Label: 6; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Intervention Type: DRUG; Name: nicotine patch; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: nicotine lozenge; Assigned to Arm(s): 2 | Intervention Type: DRUG; Name: nicotine patch + nicotine lozenge; Assigned to Arm(s): 3 | Intervention Type: DRUG; Name: bupropion; Assigned to Arm(s): 4 | Intervention Type: DRUG; Name: bupropion + lozenge; Assigned to Arm(s): 5 | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): 6

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: China Salt Substitute Study in Tibet: Efficacy of Salt Substitute in Reducing Blood Pressure in Hypertensive Adults
Brief Summary: The study was a single-blind randomized controlled trial conducted between February and August 2009 in two townships (Yangbajing and Gongtang) of Dangxiong County, an area at 4300 meters altitude in Tibet. A brief baseline survey and assessment for eligibility was performed before randomization. A total of 282 residents with known hypertension (systolic blood pressure ≥ 140mmHg) were recruited and randomly assigned to intervention or control with stratification by gender and baseline blood pressure. The intervention group received 6-month's supply of salt substitute (68% sodium chloride, 22% potassium chloride and 10% magnesium sulfate heptahydrate) and the control group 6-month's supply of regular salt (100% sodium chloride). After 3-month's intervention, the ones with a blood pressure above 140 mmHg / 90 mmHg will be given low-dose diuretic for further anti-hypertensive therapy. The study hypothesis is that salt-substitute will greatly reduce blood pressure in treated patients when compared to controls. Blood pressure levels were measured at baseline and followed up by trained observers using an automated sphygmomanometer and brief survey on level of compliance, amount of salt consumed, and reasons for non-compliance.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Dietary sodium reduction; Type: EXPERIMENTAL; Interventions: Behavioral: Dietary sodium reduction | Intervention Type: BEHAVIORAL; Name: Dietary sodium reduction; Assigned to Arm(s): Dietary sodium reduction
B: Arm Label: Salt substitute; Type: EXPERIMENTAL; Interventions: Other: Salt substitute | Intervention Type: OTHER; Name: Salt substitute; Assigned to Arm(s): Salt substitute
C: Arm Label: Normal Salt; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Regular Salt | Arm Label: Salt Substitute; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Salt Substitute | Intervention Type: DIETARY_SUPPLEMENT; Name: Regular Salt; Assigned to Arm(s): Normal Salt | Intervention Type: DIETARY_SUPPLEMENT; Name: Salt Substitute; Assigned to Arm(s): Salt Substitute
D: Arm Label: Blood pressure-measurement; Type: EXPERIMENTAL; Interventions: Device: cuff device (Omron HBP-1300-E Pro), Device: iPhone 4s | Intervention Type: DEVICE; Name: cuff device (Omron HBP-1300-E Pro); Assigned to Arm(s): Blood pressure-measurement | Intervention Type: DEVICE; Name: iPhone 4s; Assigned to Arm(s): Blood pressure-measurement

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The THERAPY Trial: The Randomized, Concurrent Controlled Trial to Assess the Penumbra System's Safety and Effectiveness in the Treatment of Acute Stroke
Brief Summary: The purpose of this trial is to assess the safety and effectiveness of the Penumbra System as an adjunctive treatment to intravenous (IV) recombinant human tissue plasminogen activator (rtPA)in patients with acute ischemic stroke from large vessel occlusion in the brain. IV rtPA is the only drug approved for the treatment of acute ischemic stroke but it does not work very well in cases where the stroke is caused by a large vessel occlusion. The hypothesis being tested is to determine if the addition of a treatment by a mechanical thrombectomy device like the Penumbra System can improve the clinical outcome of the patient over just using IV rtPA alone.


Options:
A: Arm Label: Trevo Thrombectomy Procedure; Type: EXPERIMENTAL; Interventions: Device: Trevo Thrombectomy Procedure, Other: Medical Management | Arm Label: Medical Management; Type: ACTIVE_COMPARATOR; Interventions: Other: Medical Management | Intervention Type: DEVICE; Name: Trevo Thrombectomy Procedure; Assigned to Arm(s): Trevo Thrombectomy Procedure | Intervention Type: OTHER; Name: Medical Management; Assigned to Arm(s): Medical Management, Trevo Thrombectomy Procedure
B: Arm Label: 1 Mechanical Embolectomy; Type: ACTIVE_COMPARATOR; Interventions: Device: Merci Retriever and Penumbra System | Arm Label: 2; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Merci Retriever and Penumbra System; Assigned to Arm(s): 1 Mechanical Embolectomy
C: Arm Label: IA thrombolysis; Type: EXPERIMENTAL; Interventions: Other: Alteplase IA and/or mechanical thrombolysis | Arm Label: IV rtPA; Type: ACTIVE_COMPARATOR; Interventions: Drug: Alteplase IV | Intervention Type: OTHER; Name: Alteplase IA and/or mechanical thrombolysis; Assigned to Arm(s): IA thrombolysis | Intervention Type: DRUG; Name: Alteplase IV; Assigned to Arm(s): IV rtPA
D: Arm Label: IV rtPA; Type: ACTIVE_COMPARATOR; Interventions: Drug: intravenous (IV) recombinant human tissue plasminogen activator (rtPA) | Arm Label: IV rtPA and IA Penumbra System; Type: EXPERIMENTAL; Interventions: Device: Penumbra System | Intervention Type: DRUG; Name: intravenous (IV) recombinant human tissue plasminogen activator (rtPA); Assigned to Arm(s): IV rtPA | Intervention Type: DEVICE; Name: Penumbra System; Assigned to Arm(s): IV rtPA and IA Penumbra System

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Phase 2 Study of Clinical Utility of Combination Tocolysis in Preterm Labor
Brief Summary: The purpose of this study is to compare the tocolytic efficacy, effectiveness and safety of Atosiban in comparison with the combination of Atosiban and Nifedipine together.


Options:
A: Arm Label: 1 Magnesium Sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: 1 Magnesium Sulfate | Arm Label: 2 Nifedipine; Type: ACTIVE_COMPARATOR; Interventions: Drug: Nifedipine | Arm Label: 3 Indomethacin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Indomethacin | Intervention Type: DRUG; Name: 1 Magnesium Sulfate; Assigned to Arm(s): 1 Magnesium Sulfate | Intervention Type: DRUG; Name: Nifedipine; Assigned to Arm(s): 2 Nifedipine | Intervention Type: DRUG; Name: Indomethacin; Assigned to Arm(s): 3 Indomethacin
B: Arm Label: Group 1 - Atosiban; Type: ACTIVE_COMPARATOR; Interventions: Drug: Atosiban | Arm Label: Group 2; Type: EXPERIMENTAL; Interventions: Drug: Atosiban and nifedipine | Intervention Type: DRUG; Name: Atosiban; Assigned to Arm(s): Group 1 - Atosiban | Intervention Type: DRUG; Name: Atosiban and nifedipine; Assigned to Arm(s): Group 2
C: Arm Label: Magnesium Sulfate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Magnesium Sulfate | Arm Label: Normal Saline; Type: PLACEBO_COMPARATOR; Interventions: Other: Normal Saline | Intervention Type: DRUG; Name: Magnesium Sulfate; Assigned to Arm(s): Magnesium Sulfate | Intervention Type: OTHER; Name: Normal Saline; Assigned to Arm(s): Normal Saline
D: Arm Label: A; Type: EXPERIMENTAL; Interventions: Drug: Nifedipine extended release | Arm Label: B; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Nifedipine extended release; Assigned to Arm(s): A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Individually Tailored Elastic Compression Therapy After Deep Venous Thrombosis in Relation to the Incidence of Post Thrombotic Syndrome, a Randomized Multicenter Trial
Brief Summary: In the Netherlands, 25.000 patients each year are diagnosed with Deep Venous Thrombosis (DVT). Elastic compression stocking (ECS) therapy reduces the incidence of post thrombotic syndrome (PTS) following DVT from 50% without ECS to 20-30% after ECS therapy for two years. It is however unclear whether all patients benefit to the same extent from this therapy or what the optimal duration of ECS therapy for individual patients should be. ECS therapy is not only costly, inconvenient and demanding but sometimes also even debilitating. Substantial costs could be saved by tailoring therapy to individual needs and as a result the quality of life for individual patients can be expected to improve.

This study aims to assess the costs and effects of tailoring the duration of ECS therapy after DVT to individual patients needs.

ECS therapy with a standard duration of 24 months will be compared with tailored ECS therapy, following an initial therapeutic period of 6 months, in patients with acute proximal DVT. The primary outcome is the percentage of patients with PTS at two year follow-up.

This is a multi-center, randomized, allocation concealed, single-blinded clinical trial.


Options:
A: Arm Label: A-Intervention; Type: EXPERIMENTAL; Interventions: Drug: Recombinant tissue plasminogen activator (rt-PA) | Arm Label: B-Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Recombinant tissue plasminogen activator (rt-PA); Assigned to Arm(s): A-Intervention
B: Arm Label: Intervention: individually tailored ECS; Type: EXPERIMENTAL; Interventions: Device: Individually tailored duration of elastic compression therapy | Arm Label: Control: ECS 24 months; Type: ACTIVE_COMPARATOR; Interventions: Device: Elastic compression therapy with a standard duration of 24 months | Intervention Type: DEVICE; Name: Individually tailored duration of elastic compression therapy; Assigned to Arm(s): Intervention: individually tailored ECS | Intervention Type: DEVICE; Name: Elastic compression therapy with a standard duration of 24 months; Assigned to Arm(s): Control: ECS 24 months
C: Intervention Type: DEVICE; Name: Elastic stockings; Assigned to Arm(s): N/A
D: Arm Label: I; Type: EXPERIMENTAL; Interventions: Procedure: catheter-directed venous thrombolysis | Arm Label: II; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: catheter-directed venous thrombolysis; Assigned to Arm(s): I

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Web-based Psycho-Educational Program for Informal Caregivers of Patients With Alzheimer's Disease (AD).
Brief Summary: The aim of the project is to evaluate the efficacy of a web-based psycho-educational programme designed to support informal caregivers of patients with Alzheimer's disease (AD).This program focuses on information about the illness, her progression, how to prevent psychological strain using anticipation and relaxation techniques and providing a virtual space (forum) to discuss with other caregivers.


Options:
A: Arm Label: Psycho-educational program; Type: EXPERIMENTAL; Interventions: Behavioral: psycho-social intervention based on a web-based psycho-educational program, called Diapason. | Arm Label: Standard treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Consultation in memory clinic | Intervention Type: BEHAVIORAL; Name: psycho-social intervention based on a web-based psycho-educational program, called Diapason.; Assigned to Arm(s): Psycho-educational program | Intervention Type: BEHAVIORAL; Name: Consultation in memory clinic; Assigned to Arm(s): Standard treatment
B: Arm Label: standard care; Type: OTHER; Interventions: Other: Standard care | Arm Label: mutual support group; Type: EXPERIMENTAL; Interventions: Behavioral: mutual support group | Arm Label: psychoeducation group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: psychoeducation group | Intervention Type: BEHAVIORAL; Name: mutual support group; Assigned to Arm(s): mutual support group | Intervention Type: BEHAVIORAL; Name: psychoeducation group; Assigned to Arm(s): psychoeducation group | Intervention Type: OTHER; Name: Standard care; Assigned to Arm(s): standard care
C: Arm Label: intervention; Type: EXPERIMENTAL; Interventions: Other: structured support groups | Arm Label: control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: structured support groups; Assigned to Arm(s): intervention
D: Arm Label: BHL COTP Caregivers; Type: N/A; Interventions: Behavioral: BHL COTP | Intervention Type: BEHAVIORAL; Name: BHL COTP; Assigned to Arm(s): BHL COTP Caregivers

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Web-based Psycho-Educational Program for Informal Caregivers of Patients With Alzheimer's Disease (AD).
Brief Summary: The aim of the project is to evaluate the efficacy of a web-based psycho-educational programme designed to support informal caregivers of patients with Alzheimer's disease (AD).This program focuses on information about the illness, her progression, how to prevent psychological strain using anticipation and relaxation techniques and providing a virtual space (forum) to discuss with other caregivers.


Options:
A: Arm Label: Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: My Tools 4 Care | Arm Label: Educational Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: My Tools 4 Care; Assigned to Arm(s): Intervention
B: Arm Label: Psycho-educational program; Type: EXPERIMENTAL; Interventions: Behavioral: psycho-social intervention based on a web-based psycho-educational program, called Diapason. | Arm Label: Standard treatment; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Consultation in memory clinic | Intervention Type: BEHAVIORAL; Name: psycho-social intervention based on a web-based psycho-educational program, called Diapason.; Assigned to Arm(s): Psycho-educational program | Intervention Type: BEHAVIORAL; Name: Consultation in memory clinic; Assigned to Arm(s): Standard treatment
C: Arm Label: Navigated Care; Type: EXPERIMENTAL; Interventions: Behavioral: Navigated Care | Arm Label: Survey of Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Navigated Care; Assigned to Arm(s): Navigated Care
D: Arm Label: Immediately Receive Tool; Type: EXPERIMENTAL; Interventions: Behavioral: Immediately Receive Tool | Arm Label: One Month Delay; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: One Month Delay | Intervention Type: BEHAVIORAL; Name: Immediately Receive Tool; Assigned to Arm(s): Immediately Receive Tool | Intervention Type: BEHAVIORAL; Name: One Month Delay; Assigned to Arm(s): One Month Delay

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (ICAC-20)
Brief Summary: The purpose of this trial is to compare the efficacy of 4 to 5 months of three treatments - omalizumab, corticosteroid therapy boost, and placebo - in reducing fall exacerbations in inner-city children and adolescents with allergic persistent asthma when initiated approximately 4 -6 weeks prior to the start of the first day of each participant's school year.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: montelukast | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Comparator: Placebo | Intervention Type: DRUG; Name: montelukast; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Comparator: Placebo; Assigned to Arm(s): 2
B: Arm Label: Two Step Hand-Hygiene; Type: EXPERIMENTAL; Interventions: Other: Active Hand Sanitizer | Arm Label: Usual Care Hand Hygiene; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Active Hand Sanitizer; Assigned to Arm(s): Two Step Hand-Hygiene
C: Arm Label: Omalizumab; Type: EXPERIMENTAL; Interventions: Biological: Omalizumab, Biological: Placebo fluticasone | Arm Label: Inhaled Corticosteroid Boost Therapy (ICS); Type: EXPERIMENTAL; Interventions: Drug: Inhaled Corticosteroid Boost Therapy (ICS), Biological: Placebo omalizumab | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Biological: Placebo omalizumab, Biological: Placebo fluticasone | Intervention Type: BIOLOGICAL; Name: Omalizumab; Assigned to Arm(s): Omalizumab | Intervention Type: DRUG; Name: Inhaled Corticosteroid Boost Therapy (ICS); Assigned to Arm(s): Inhaled Corticosteroid Boost Therapy (ICS) | Intervention Type: BIOLOGICAL; Name: Placebo omalizumab; Assigned to Arm(s): Inhaled Corticosteroid Boost Therapy (ICS), Placebo | Intervention Type: BIOLOGICAL; Name: Placebo fluticasone; Assigned to Arm(s): Omalizumab, Placebo
D: Arm Label: FLOVENT™ DISKUS™ 100 mcg; Type: ACTIVE_COMPARATOR; Interventions: Drug: FLOVENT™ DISKUS™ 100 mcg BID | Arm Label: ADVAIR™ DISKUS™ 100/50 mcg; Type: EXPERIMENTAL; Interventions: Drug: ADVAIR™ DISKUS™ 100/50 mcg BID | Intervention Type: DRUG; Name: FLOVENT™ DISKUS™ 100 mcg BID; Assigned to Arm(s): FLOVENT™ DISKUS™ 100 mcg | Intervention Type: DRUG; Name: ADVAIR™ DISKUS™ 100/50 mcg BID; Assigned to Arm(s): ADVAIR™ DISKUS™ 100/50 mcg

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Postrape Drug Abuse: Replication Study
Brief Summary: The purpose of this study is to evaluate whether a brief intervention in video format, that includes education about reactions to assault and modeling of adaptive coping strategies, designed to reduce post assault drug use or abuse and PTSD and shown to recent victims of sexual assault at the time of receipt of post assault medical care is associated with better post-assault outcomes as compared to a comparable length video that includes pleasant imagery and relaxation instruction or standard care.


Options:
A: Arm Label: Control - VSLA; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control - Mental Health; Type: OTHER; Interventions: Behavioral: Treatment as usual | Arm Label: Voluntary Savings/Loans Assoc; Type: EXPERIMENTAL; Interventions: Behavioral: Voluntary Savings/Loans Assoc | Arm Label: Cognitive Processing Therapy; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy | Intervention Type: BEHAVIORAL; Name: Treatment as usual; Assigned to Arm(s): Control - Mental Health | Intervention Type: BEHAVIORAL; Name: Voluntary Savings/Loans Assoc; Assigned to Arm(s): Voluntary Savings/Loans Assoc | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): Cognitive Processing Therapy
B: Arm Label: PPRS video; Type: EXPERIMENTAL; Interventions: Behavioral: PPRS | Arm Label: PIRI video; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: PIRI | Arm Label: Standard care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: PPRS; Assigned to Arm(s): PPRS video | Intervention Type: BEHAVIORAL; Name: PIRI; Assigned to Arm(s): PIRI video
C: Arm Label: Brief Cognitive Intervention; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Brief Cognitive Therapy | Arm Label: Assessment Only; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Brief Cognitive Therapy; Assigned to Arm(s): Brief Cognitive Intervention
D: Arm Label: CBT for PTSD; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for PTSD | Arm Label: Imagery Rehearsal Therapy + CBT for PTSD; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy for PTSD, Behavioral: Imagery Rehearsal Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for PTSD; Assigned to Arm(s): CBT for PTSD, Imagery Rehearsal Therapy + CBT for PTSD | Intervention Type: BEHAVIORAL; Name: Imagery Rehearsal Therapy; Assigned to Arm(s): Imagery Rehearsal Therapy + CBT for PTSD

Answer: B